{
  "ticker": "LLY",
  "target_date": "2025-10-10",
  "actual_date": "2025-10-10",
  "collected_at": "2025-12-08T12:23:34.628461",
  "price": {
    "open": 856.74,
    "high": 863.08,
    "low": 828.89,
    "close": 832.2677001953125,
    "volume": 3431000,
    "change_1d_pct": -2.56,
    "change_7d_pct": 0.98,
    "change_30d_pct": 13.87
  },
  "technicals": {
    "rsi_14": 68.1,
    "sma_20": 782.29,
    "sma_50": 741.74,
    "macd": 28.751,
    "macd_signal": 21.015,
    "macd_histogram": 7.736,
    "bb_upper": 878.97,
    "bb_lower": 685.61,
    "price_vs_sma20_pct": 6.39,
    "price_vs_sma50_pct": 12.2,
    "volume_ratio": 0.84
  },
  "fundamentals": {
    "market_cap": 892835069952,
    "pe_ratio": 48.79765,
    "forward_pe": 43.95234,
    "price_to_book": 37.498497,
    "price_to_sales": 15.025885,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.43,
    "pct_from_52w_low": 59.67
  },
  "macro": {
    "spy": {
      "price": 653.02,
      "change_1d_pct": -2.7,
      "change_7d_pct": -2.42
    },
    "vix": {
      "level": 21.66,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.05
    },
    "dollar_index": {
      "level": 98.98
    },
    "gold": {
      "price": 3975.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1760113860,
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=0f3a907be4929dc225a3ee448761ab397cccc100b636320ce0457e7b112ef119"
    },
    {
      "headline": "IWY: Benefits And Risks Of This Concentrated Growth ETF",
      "source": "SeekingAlpha",
      "datetime": 1760107473,
      "summary": "Discover if iShares Russell Top 200 Growth ETF (IWY) fits your portfolio. Compare performance, risks, and sector focus with QQQ.",
      "url": "https://finnhub.io/api/news?id=5383cc831399dc2f6f541807acec6d4ba460f75dcf2ce5f3f1f1279f187a9109"
    },
    {
      "headline": "Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance?",
      "source": "Yahoo",
      "datetime": 1760104440,
      "summary": "NVO's $4.7B acquisition of Akero Therapeutics adds a late-stage MASH therapy to its obesity-linked pipeline, advancing its expansion goal beyond semaglutide.",
      "url": "https://finnhub.io/api/news?id=f544989ccd590c7e3581e2712d42bb71f93d41b79fcfb091e5eed876dcf0311f"
    },
    {
      "headline": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
      "source": "Yahoo",
      "datetime": 1760101202,
      "summary": "Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=080eef923e4f3ebd14bcb8eab04ea8fa6912367907d7f34f6c78d0ae5e38fe33"
    },
    {
      "headline": "Market Chatter: Gates Foundation, PAHO Eye Expanded Access to Weight-Loss Drugs in Lower-Income Countries",
      "source": "Yahoo",
      "datetime": 1760095846,
      "summary": "The Gates Foundation and the Pan American Health Organization, or PAHO, are looking to expand access",
      "url": "https://finnhub.io/api/news?id=5caa2c42a9e1fbc6ae5dbbbfa6ed4c12962734ac67da855ee5975fe0c2126b1e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-10-10",
      "description": "xslF345X05/form4-10102025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000035/xslF345X05/form4-10102025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-09",
      "description": "xslF345X05/form4-10092025_041002.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000031/xslF345X05/form4-10092025_041002.xml"
    },
    {
      "form": "4",
      "date": "2025-10-08",
      "description": "xslF345X05/form4-10082025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000029/xslF345X05/form4-10082025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-07",
      "description": "xslF345X05/form4-10072025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000027/xslF345X05/form4-10072025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-06",
      "description": "xslF345X05/form4-10062025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000025/xslF345X05/form4-10062025_041001.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}